Dialysis: Clinical Trials

8 trials for Dialysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 3, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1

Follow Dialysis: new trials by email Literature Review of Dialysis trials Research Report on Dialysis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CANagliflozin In DIALysis Patients
Invokana 300 mg and 100 mg tablet - Dialysis, Chronic Kidney Disease (Stages 4 and 5)
Phase 4Not yet recruitingUniversity Medical Center Groningen102026-06-012026-05-06
Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
Semaglutide Pen - Kidney Disease, Chronic, Diabetes
Phase 4RecruitingUnity Health Toronto1002025-11-272026-06-26
Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
Aliskiren - Hypertension, Dialysis
Phase 4UnknownUniversity of Campania Luigi Vanvitelli3502009-09-012012-07-10
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
Calcitriol, Paricalcitol - Secondary Hyperparathyroidism, Dialysis
Phase 4TerminatedAbbott132009-01-012012-01-20
Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
Eplerenone, Placebo - Hypertension, Dialysis
Phase 4UnknownShaare Zedek Medical Center272007-11-012007-11-06
Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients
catheter for AV fistula cannulation - Dialysis, Fistula
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven402007-10-012011-12-20
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
Paricalcitol injection, Paricalcitol capsules - Secondary Hyperparathyroidism, Dialysis
Phase 4CompletedAbbott1472007-09-012011-10-25
Very Low Protein Diet or Dialysis in Uremic Elderly?
mixture of amino and keto acids - Uremia, Elderly (Aged >70)
Phase 4CompletedUniversità degli Studi di Brescia1602000-01-012006-10-17

Narrower conditions

Hyperparathyroidism, Secondary (2)  ·  Hypertension (2)  ·  Renal Insufficiency, Chronic (2)  ·  Aneurysm (1)  ·  Anxiety Disorders (1)  ·  Arteriovenous Fistula (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fistula (1)  ·  Hyperaldosteronism (1)  ·  Hyperparathyroidism (1)  ·  Kidney Failure, Chronic (1)  ·  Pain (1)  ·  Uremia (1)

Broader conditions

Endocrine System Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Vascular Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Parathyroid Diseases (2)  ·  Pathologic Processes (2)  ·  Renal Insufficiency (2)

Interventions

paricalcitol (2)  ·  Amlodipine (1)  ·  Calcitriol (1)  ·  Canagliflozin (1)  ·  Catheters (1)  ·  Eplerenone (1)  ·  Keto Acids (1)  ·  Tablets (1)  ·  aliskiren (1)

Sponsors

Abbott (2)  ·  Shaare Zedek Medical Center (1)  ·  Unity Health Toronto (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Medical Center Groningen (1)  ·  University of Campania Luigi Vanvitelli (1)  ·  Università degli Studi di Brescia (1)

Countries

Italy (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Israel (1)  ·  Mexico (1)  ·  Netherlands (1)

Top investigators

Bert RM Bammens, MD, PhD (1)  ·  Dr. Ron Wald, MD (1)  ·  Linda Shavit, MD (1)  ·  Lino Rodrigues, MD (1)

Results publications

PMID 10946805, PMID 17472838, PMID 33000470

NIH funding

2025 (1)